Radna Vadlamudi, PhD (IMAGE)

University of Texas Health Science Center at San Antonio

Radna Vadlamudi, PhD

Caption

Radna Vadlamudi, PhD, of The University of Texas Health Science Center at San Antonio, is part of a team reporting the promising effects of a compound against a range of difficult-to-treat cancers. The study, published June 2, 2022, in Nature Cancer, points to the compound's targeting of a previously unrecognized vulnerability in several cancers, including triple-negative breast cancer.

Credit

UT Health San Antonio

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.